Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals — including high-cost oral and injectable medications used to treat complex chronic conditions — across both domestic and international markets.
The company’s portfolio includes a wide range of speciality pharmaceutical finished formulations products, which are available in various dosage forms such as tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions.
The company operates via two models: (a) contract manufacturing of finished formulations for international distribution, and (b) marketing and distribution of sourced specialty pharmaceutical products.
The company has expanded internationally with registered or pending products in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia. Its distribution network builds strong relationships across over 20 states in India and more than 35 countries worldwide world.
As of Feb 28, 2026, the company has 7 products registered overseas and 54 products are in the registration process across 5 countries.
Competitive Strengths
| Period Ended | 31 Oct 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 45.57 | 39.98 | 22.68 |
| Total Income | 36.93 | 58.54 | 27.66 |
| Profit After Tax | 6.06 | 8.61 | 2.93 |
| EBITDA | 6.51 | 9.09 | 5.26 |
| NET Worth | 36.47 | 30.42 | 15.06 |
| Reserves and Surplus | 30.04 | 23.98 | 9.95 |
| Total Borrowing | 4.81 | 5.05 | 2.86 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje, Manda, Tal. Umargam, Dist. Valsad, Gujarat | 12.68 |
| 2 | Product Registration in International Markets and Product Development for sale in international markets | 2.99 |
| 3 | Funding for Marketing and Promotional Activities | 1.66 |
| 4 | To Meet Working Capital Requirements | 8.00 |
| 5 | General Corporate Purposes | |
| Total | 25.33 |
| KPI | Oct 31, 2025 | Mar 31, 2025 |
|---|---|---|
| ROE | 18.11% | 37.85% |
| ROCE | 16.68% | 33.39% |
| Debt/Equity | 0.13 | 0.17 |
| RoNW | 16.61% | 28.30% |
| PAT Margin | 16.49% | 14.77% |
| EBITDA Margin | 17.73% | 15.60% |
| Price to Book Value | 2.19 | 2.62 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 13.38 | 11.82 |
| P/E (x) | 9.27 | 10.49 |
| IPO Date | 20 to 24 Mar, 2026 |
| Listing Date | Mon, Mar 30, 2026T |
| Face Value | ₹10 per share |
| Price Band | ₹117 to ₹124 |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Total Issue Size | 23,50,000 shares (agg. up to ₹29 Cr) |
| Reserved for Market Maker |
1,50,000 shares
(agg. up to ₹2 Cr) |
| Fresh Issue (Ex Market Maker) | 22,00,000 shares (agg. up to ₹27 Cr) |
| Net Offered to Public | 22,00,000 shares (agg. up to ₹27 Cr) |
| Share Holding Pre Issue | 64,35,796 shares |
| Share Holding Post Issue | 87,85,796 shares |
Parth B Goyani and Goyani Sumit Babubhai are the company promoters.
| Share Holding Pre Issue | 59.67% |
| Share Holding Post Issue |
As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in
The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.
Last Updated on March 19, 2026 Speciality Medicines ltd IPO Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals —
Last Updated on March 19, 2026 Central Mine Planning & Design Institute Ltd Incorporated in 1974, Central Mine Planning & Design Institute Limited (CMPDI) offers consultancy and support services across
Last Updated on March 14, 2026 Novus Loyalty Ltd. IPO Incorporated in 2011, Novus Loyalty is a technology-driven company that provides loyalty and rewards solutions for industries like Fintech, E-commerce,
You can contribute as little as
100, 200, 500 & so…
every bit counts.
